Remicade (infliximab) - J&J
Humira (adalimumab) - AbbVie
Tafinlar (dabrafenib) - Novartis
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Entyvio (vedolizumab) - Takeda
azathioprine - Generic mfg.
Dificid (fidaxomicin) - Merck (MSD), Astellas
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=830116&rnd=0.5494602
 
Emma Terwilliger MD 1; Geoff J. Thomas MD 2; Leticia Assad Maia Sandoval MD 1; Pierce Claassen MD 3; Taylor Viggiano MD 2; Davyani Rozera MBBS 4; Stacey Rolak MD 1; Amani Elshaer MBBS 5; Marcela Salomao MD 2; Mashal J. Batheja MD 2; Anna Silverman MD 2; Christina Ha MD FACG 2
 
Aug 29, 2026
 
Prev Next